A Study to Assess the PK and Pharmacodynamics of IPX203 in Patients With Advanced Parkinson's Disease
Public ClinicalTrials.gov record NCT02271503. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Study to Assess the Pharmacokinetics and Pharmacodynamics of a Single Dose of IPX203 in Patients With Advanced Parkinson's Disease
Study identification
- NCT ID
- NCT02271503
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Impax Laboratories, LLC
- Industry
- Enrollment
- 26 participants
Conditions and interventions
Conditions
Interventions
- CD-LD IR Drug
- IPX203 180 mg Drug
- IPX203 270 mg Drug
- Rytary 145 mg Drug
- Rytary 195 mg Drug
Drug
Eligibility (public fields only)
- Age range
- 40 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2015
- Primary completion
- Jul 31, 2016
- Completion
- Jul 31, 2016
- Last update posted
- Nov 5, 2019
2015 – 2016
United States locations
- U.S. sites
- 11
- U.S. states
- 9
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Muhammad Ali Movement Disorder Center (MAMDC) | Phoenix | Arizona | 85013 | — |
| Clinical Trials, Inc. | Little Rock | Arkansas | 72205 | — |
| The Parkinson's and Movement Disorder Institute | Fountain Valley | California | 92708 | — |
| Parkinson's Disease and Movement Disorders Center of Boca Raton | Boca Raton | Florida | 33486 | — |
| Collier Neurologic Specialists | Naples | Florida | 34102 | — |
| University of South Florida Parkinson's Disease and Movement Disorder Center | Tampa | Florida | 33613 | — |
| Georgia Regents University | Augusta | Georgia | 30912 | — |
| QUEST Research Institute | Farmington Hills | Michigan | 48334 | — |
| Duke University Movement Disorders Clinic | Durham | North Carolina | 27705 | — |
| University Hospitals Case Medical Center | Cleveland | Ohio | 44106 | — |
| Premier Clinical Research | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02271503, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 5, 2019 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02271503 live on ClinicalTrials.gov.